Haemophilus influenzae type b Vaccine
The H. influenzae disease encompasses all infections caused by the H. influenzae bacteria (Hib). Such infections can range from mild inconveniences, like ear infections, to serious issues, like bloodstream infections. Common infections include Pneumonia, bloodstream infections, Meningitis, Epiglottitis (swelling of the throat), Cellulitis (a skin infection), and Infectious arthritis (joint swelling). The bacteria live in people’s noses and throats, usually causing no harm. However, issues arise when these bacteria move to other parts of the body.
Source: CDC
The Case For the Vaccine
The case for the vaccine: Researchers credit the Hib vaccine with nearly eliminating one of the largest groups of bacterial infections in babies and toddlers. Before the vaccine, around twenty thousand children contracted Hib. Of those twenty thousand cases, one thousand deaths were reported. Since the vaccine’s infancy, the United States has recorded fewer than fifty Hib cases per year, mainly in children who have not gotten all of their immunizations.
Source: Babycenter
The Case Against the Vaccine
Researchers have observed a seizure risk post-vaccination, leading to elevated levels of concern in parents. As with other vaccines, specific brands of this immunization include aluminum and formaldehyde.
Source: CDC
Conclusion
Data paints this vaccine in a favorable light. Hospitalizations and deaths stemming from Hib have been drastically reduced in recent years. However, certain vaccine ingredients and side effects have raised concern. Before deciding whether to vaccinate your child, we challenge you to research the various vaccine providers, each one’s side effects, and ingredients. Sanofi Pasteur’s ActHib option contains no aluminum or formaldehyde, which appeals to some parents interested in eliminating such exposure.
Source: Sanofi Pasteur Inc.